<DOC>
	<DOCNO>NCT01882361</DOCNO>
	<brief_summary>To address question comparison two course Vivitrol differ lengths 130 HIV negative , consent , opioid addict patient complete inpatient treatment . Participants randomize double blind condition 24 48-week course pharmacotherapy , along bi-weekly drug counselling , 48 week , follow-ups week 60 72 . The 24-week cohort receive Vivitrol placebo injection week 24 48 .</brief_summary>
	<brief_title>Opioid Relapse &amp; HIV Risk : 48 Versus 24 Weeks Injectable Extended Release Naltrexone</brief_title>
	<detailed_description>1.2.1 Primary Secondary Outcome Measures Primary outcome : 1 ) Opiate positive urine test ; 2 ) HIV inject risk . Secondary outcome : 1 ) Time relapse ; 2 ) HIV sex risk ; 3 ) Proportion appointment keep ; 6 ) Psychiatric symptom ; 7 ) Opioid craving ; 8 ) Self-reported drug use ; 9 ) Money spent drug ; 10 ) Employment ; 11 ) Arrests ; 12 ) Overall adjustment ; 12 ) Adverse event . Hypotheses : 1 . Primary outcome significantly favor 48-week Vivitrol condition ; 2 . Five secondary outcome favor 48-week condition ; none favor 24-week condition .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>HIVnegative men woman 18 year age old meet Diagnostic Statistical Manual Mental Disorders 4th editionText Revision ( DSM IVTR ) criteria opioid dependence Must voluntarily seek treatment opioid dependence , injection heroin drug administration route choice Must report share injection equipment past year Must successfully complete inpatient detoxification Federal Medical Research Center Psychiatry Narcology ( FMRCPN ) Must current evidence physiologic dependence Must stable address Moscow telephone number reach If female , must negative pregnancy test use medically acceptable contraception childbearing age Must able provide inform consent judge ability read consent correctly answer 9 10 question study quiz No current condition psychosis ( schizophrenia , paranoid disorder , mania ) No history major psychiatric disorder Schizophrenia , Major Depression suicidal attempt , Bipolar I , uncontrolled epilepsy seizure disorder No current dependence ( within past year ) drug prescription opiates heroin , caffeine , marijuana , nicotine base Diagnostic Statistical Manual Mental DisordersText Revision ( DSM IVTR ) criteria No current alcohol dependence alcohol use disorder would preclude successful completion study procedures No current suicidal homicidal ideation require immediate attention determine baseline assessment No cognitive impairment inability read understand consent No significant laboratory abnormality haemoglobin &lt; 10 , hepatic transaminase level &gt; 3 time upper limit normal serum creatinine &gt; 1.5 time upper limit normal No legal charge impend incarceration No concurrent participation another treatment study Can schedule surgery likely require opioids pain control next 2 year Not currently take naltrexone currently receive treatment ( pharmacological behavioral ) drug dependence currently receive psychoactive medication Can receipt approve investigational depot product administer gluteal muscle within 6 month screen Can exclude medication screen anticipate use exclude medication study period Can participate clinical trial pharmacological agent within 30 day prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>opioid addiction</keyword>
	<keyword>opioid treatment</keyword>
	<keyword>naloxone</keyword>
</DOC>